📗 Cite This Artifact
Indonesia Neurodegeneration Biotech Companies
Overview
Indonesia has the largest population in Southeast Asia and a growing pharmaceutical and biotechnology sector. The country's pharmaceutical industry has been expanding its research capabilities, with increasing interest in neurological and neurodegenerative disease research. Several large pharmaceutical companies and emerging biotech firms are developing treatments for CNS disorders.
Large Pharmaceutical Companies
PT Kalbe Farma TBK
Headquarters: Jakarta, Indonesia Ticker: IDX: KLFA Website: https://www.kalbefarma.com...
Overview
Indonesia has the largest population in Southeast Asia and a growing pharmaceutical and biotechnology sector. The country's pharmaceutical industry has been expanding its research capabilities, with increasing interest in neurological and neurodegenerative disease research. Several large pharmaceutical companies and emerging biotech firms are developing treatments for CNS disorders.
Large Pharmaceutical Companies
PT Kalbe Farma TBK
Headquarters: Jakarta, Indonesia Ticker: IDX: KLFA Website: https://www.kalbefarma.comKalbe Farma is Indonesia's largest pharmaceutical company with diverse therapeutic areas including CNS and neurological disorders. The company has established research partnerships for developing treatments for [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
- Focus: CNS disorders, Oncology, Vaccines
- Pipeline: CNS therapeutic development programs
- Approach: In-house R&D, Partnerships
PT Bio Farma (Persero)
Headquarters: Bandung, Indonesia Website: https://www.biofarma.co.idBio Farma is an Indonesian state-owned pharmaceutical company primarily focused on vaccines but has expanded into other therapeutic areas including neurological disorders. The company collaborates with international organizations for research and development.
- Focus: Vaccines, Immunology, CNS disorders
- Approach: Vaccine and immunotherapy development
PT Kimia Farma TBK
Headquarters: Jakarta, Indonesia Ticker: IDX: KAEF Website: https://www.kimiafarma.co.idKimia Farma is one of Indonesia's oldest pharmaceutical companies with growing capabilities in CNS drug development. The company has research programs targeting neurodegenerative diseases.
- Focus: Generic pharmaceuticals, CNS drugs
- Research: Neurodegeneration partnerships
PT Indofarma TBK
Headquarters: Jakarta, Indonesia Ticker: IDX: INAF Website: https://www.indofarma.co.idIndofarma is an Indonesian pharmaceutical company with focus on CNS therapeutics. The company develops generic medications and has interests in neurological disorder treatments.
- Focus: CNS disorders, Anti-infectives
- Approach: Generic pharmaceuticals
PT Sanbe Farma
Headquarters: Bandung, Indonesia Website: https://www.sanbefarma.comSanbe Farma is a major Indonesian pharmaceutical company with a growing CNS portfolio. The company has established research collaborations for neurodegenerative disease drug development.
- Focus: CNS disorders, Metabolic diseases
- Pipeline: CNS development programs
PT Dexa Medica
Headquarters: Jakarta, Indonesia Website: https://www.dexa-medica.comDexa Medica is an Indonesian pharmaceutical company focused on CNS and neurological disorders. The company has research partnerships with international institutions for drug discovery.
- Focus: CNS disorders, Inflammation
- Approach: Drug discovery, Clinical development
PT Ethica Industri Farmasi
Headquarters: Jakarta, Indonesia Website: https://www.ethica.co.idEthica is an Indonesian pharmaceutical company specializing in specialty pharmaceuticals including CNS drugs. The company develops treatments for neurological and neurodegenerative conditions.
- Focus: CNS disorders, Specialty pharmaceuticals
- Approach: Licensed products, In-house development
Emerging Biotech Companies
Combiphar Labs
Headquarters: Jakarta, IndonesiaCombiphar is an Indonesian pharmaceutical company with growing interest in CNS disorders. The company has research programs targeting neurodegenerative diseases.
- Focus: CNS disorders, Consumer health
- Approach: Drug development
Phapros TBK
Headquarters: Surabaya, Indonesia Ticker: IDX: PCAR Website: https://www.phapros.co.idPhapros is an Indonesian pharmaceutical company with expanding CNS portfolio. The company develops treatments for neurological disorders.
- Focus: CNS disorders, Cardiovascular
- Approach: Generic and novel therapeutics
Research Institutions
Eijkman Institute for Molecular Biology
Location: Jakarta, IndonesiaThe Eijkman Institute conducts research in molecular biology and genetics relevant to neurodegenerative diseases, with collaborations with pharmaceutical companies.
Universitas Indonesia - Faculty of Medicine
Location: Jakarta, IndonesiaUI has neuroscience research programs with industry partnerships for drug discovery.
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | companies-indonesia-neurodegeneration-biotech |
| kg_node_id | None |
| entity_type | company |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-c5e1ffab40f2 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'companies-indonesia-neurodegeneration-biotech'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-companies-indonesia-neurodegeneration-biotech?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Indonesia Neurodegeneration Biotech Companies](http://scidex.ai/artifact/wiki-companies-indonesia-neurodegeneration-biotech)
http://scidex.ai/artifact/wiki-companies-indonesia-neurodegeneration-biotech